| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_097d66a06083fc5c907e4f62f8530bc3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_63234c9e2a3497ab1174c6de5d961204
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0853f14a64b16d1710f4315d150da980
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f47749d67bddb2cafa5a049ecca0cb51 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0091
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6943
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-549
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6903 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate |
2007-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bd2f88c1a98b5be99805e34daee9a45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c67afd01f29a0f9b90eb95d158eb4f71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_580dd60dd687a09bd0b9197b5e8cb709 |
| publicationDate |
2008-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008060575-A2 |
| titleOfInvention |
Drug delivery system and method |
| abstract |
A system for delivering a therapeutic dose of a drug is disclosed. The system includes a delivery medium with therapeutic units attached thereto. The delivery medium is preferably a polymeric hydrogel matrix that has therapeutic units incorporated therein or metal nanoparticles with therapeutic units complexed thereto. The therapeutic units include nucleic acid moieties. The nucleic acid moieties preferably include strands of nucleic acid and drug moieties complexed with the strands of nucleic acid. Where the system includes a polymeric hydrogel matrix, an active drug is controllably released from the polymer hydrogel matrix to provide a therapeutic dose to a biological system or biological tissue. The active drug is controllably released from the hydrogel matrix by altering the environment the hydrogel matrix, or by enzymatic cleavage of the nucleic acid moieties or by a combination thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11666515-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11369570-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2645991-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10285943-B2 |
| priorityDate |
2006-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |